drugset / Trial / NCT01471613
Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury
Phase 1/2
Completed
16 enrolled
China Spinal Cord Injury Network
Chengdu PLA General Hospital · collabStemCyte, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The trial is to investigate the safety and efficacy of oral lithium, intraspinal umbilical cord blood mononuclear cell transplant, and the combination in the treatment of acute and subacute spinal cord injury
Timeline
- Start
- 2011-09
- Primary completion
- 2013-12
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cord Blood Cell | Cell therapy | 6.4e+06 cells | Other |
| Subject | Lithium Carbonate | Unknown | 250 mg | Oral |